Valid for Submission
D57.413 is a billable diagnosis code used to specify a medical diagnosis of sickle-cell thalassemia, unspecified, with cerebral vascular involvement. The code D57.413 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
Unspecified diagnosis codes like D57.413 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code D57.413:
Code AlsoCode Also
A "code also" note instructs that two codes may be required to fully describe a condition, but this note does not provide sequencing direction.
- , if applicable cerebral infarction I63
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code D57.413 are found in the index:
- - Disease, diseased - See Also: Syndrome;
- - Hemoglobinopathy (mixed) - D58.2
D57413 replaces the following previously assigned ICD-10 code(s):